Previous 10 | Next 10 |
home / stock / elan / elan articles
Elanco Animal Health Incorporated (NYSE:ELAN) reported first-quarter adjusted EPS of $0.34, down 26% year over year, beating the con...
Shares of Upstart Holdings, Inc. (NASDAQ:UPST) fell sharply during Wednesday's session after the company reported first-quarter financial resu...
U.S. stocks were mixed, with the Dow Jones gaining around 70 points on Wednesday. Shares of Louisiana-Pacific Corporation (NYSE:LPX) rose sharply d...
New Directors Join the Board's Renamed Finance, Strategy and Oversight Committee Reaches Cooperation Agreement with Ancora GREENFIELD, Ind., A...
Elanco Animal Health Inc (NYSE:ELAN) reported fourth-quarter 2023 revenue of $1.035 billion, up 5% reported growth or 5% excluding the impact ...
Elanco Animal Health Inc (NYSE:ELAN) reported fourth-quarter 2023 revenue of $1.035 billion, up 5% reported growth or 5% excluding the impact ...
After last week’s robust gains, sentiment appears to have shifted back to caution, with index futures indicating a slightly lower openin...
Merck Animal Health, a division of Merck & Co Inc (NYSE:MRK), has agreed to acquire Elanco Animal Health Incorporated’s aq...
U.S. stocks traded lower, with the Dow Jones falling over 300 points on Monday. Shares of The Estée Lauder Companies Inc. (NYSE: EL) rose s...
News, Short Squeeze, Breakout and More Instantly...
Elanco Animal Health Incorporated Company Name:
ELAN Stock Symbol:
NYSE Market:
Elanco Animal Health Incorporated Website:
NEW YORK CITY, NY / ACCESSWIRE / July 1, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN). Investors who purchased Elanco securities are encouraged to obtain additi...
2024-07-01 07:00:08 ET David Westenberg from Piper Sandler issued a price target of $16.00 for ELAN on 2024-07-01 06:25:00. The adjusted price target was set to $16.00. At the time of the announcement, ELAN was trading at $14.43. The overall price target consensus is at ...
Elanco Provides Innovation Update PR Newswire Major technical sections complete for Zenrelia, with FDA final approval on track for late in third quarter of 2024; updates on differentiation and safety Final FDA approval for Credelio Quattro now expected in the fo...